Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUBLIN-3: Docetaxel + Plinabulin vs Docetaxel in Advanced NSCLC
NCT02504489Phase 3Completed
- Sponsor
- BeyondSpring Inc.
- Start
- Dec 2015
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of plinabulin in non-small cell lung cancer (NSCLC), sponsored by BeyondSpring Inc.. Started Dec 2015; status: completed.
02
Drugs
plinabulin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02504489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504489.